Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Metastatic Cancer, Prostate Cancer
Study Phase
Phase 3
Study Completion Date
February 2016
NCT00134056Uploaded 10-09-2021
Access via NCI by Request
PDS UID: nci-data-485
Phase III Study of Docetaxel and Atrasentan Versus Docetaxel and Placebo for Patients With Advanced Hormone Refractory Prostate Cancer
Files: NCT00134056-D1
Data DictionaryNCT00134056-D1-Data-Dictionary_0.pdf
DATANCT00134056-D1-Dataset_0.csv
OTHERREADME.pdf